c-Myc alone is enough to reprogram fibroblasts into functional macrophages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

c-Myc alone is enough to reprogram fibroblasts into functional macrophages

Published:2024-09-12 Issue:1 Volume:17 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Li Shanshan,Chen Guoyu,Huang Xia,Zhang Yingwen,Shen Shuhong,Feng Haizhong,Li Yanxin

Funder

National Natural Science Foundation of China

the National Key Research and Development Program of China

Program of Shanghai Academic/Technology Research Leader

Shanghai Natural Science Foundation

Shanghai Municipal Science and Technology Commission

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13045-024-01605-x.pdf

Reference38 articles.

1. Flugel CL, Majzner RG, Krenciute G, et al. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours [J]. Nat Rev Clin Oncol. 2023;20(1):49–62.

2. Cappell KM, Kochenderfer JN. Long-term outcomes following CAR T cell therapy: what we know so far [J]. Nat Rev Clin Oncol. 2023;20(6):359–71.

3. Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy [J]. Nat Rev Drug Discov. 2022;21(11):799–820.

4. Klichinsky M, Ruella M, Shestova O, et al. Human chimeric antigen receptor macrophages for cancer immunotherapy [J]. Nat Biotechnol. 2020;38(8):947–53.

5. Zhang L, Tian L, Dai X, et al. Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions [J]. J Hematol Oncol. 2020;13(1):153.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP